Chongqing Daxin Pharmaceutical Co., Ltd.
Profile: Chongqing Daxin Pharmaceutical Co., Ltd. is a producer of plasma drugs and pharmaceutical intermediates. Our APIs include allopurinol, midecamycin, amikacin, tobramycin, lovastatin, simvastatin, glucose, mycophenola, bambermycin and vancomycin. Our allopurinol inhibits xanthine oxidase which can prevent hypoxanthine or xanthine from transforming into acidum uricum. Our lovastatin is used in the prevention of coronary atherosclerosis and in the treatment of primary hypercholesterolemia.